m6A RNA methylation impacts fate choices during skin morphogenesis

  1. Linghe Xi
  2. Thomas Carroll
  3. Irina Matos
  4. Ji-Dung Luo
  5. Lisa Polak
  6. H Amalia Pasolli
  7. Samie R Jaffrey
  8. Elaine Fuchs  Is a corresponding author
  1. Howard Hughes Medical Institute, Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, United States
  2. Bioinformatics Resource Center, The Rockefeller University, United States
  3. Electron Microscopy Resource Center, The Rockefeller University, United States
  4. Department of Pharmacology, Weill Cornell Medicine, Cornell University, United States
7 figures, 1 table and 7 additional files

Figures

Figure 1 with 1 supplement
miCLIP and ribosomal profiling analyses of the mouse skin epithelial progenitors.

(A) Schematic depicting the major factors involved in regulating the cellular dynamics of m6A modification. (B) Schematic depicting embryonic development of mammalian epithelial skin progenitors. …

Figure 1—figure supplement 1
miCLIP experiment setup and correlation analysis.

(A) Hematoxylin and eosin (H and E) stained sagittal sections of wild-type P0 back skin before and after dispase treatment (scale bars: 50 µm). (B) Sorting strategy to isolate basal skin progenitors …

Figure 2 with 2 supplements
Krt14-Cre driven conditional Mettl3 knockout mice display severe defects in HF morphogenesis.

(A) Representative pictures of Krt14-Cre-/-, Rosa26-YFPfl/+ and Krt14-Cre+/-, Rosa26-YFPfl/+ littermate embryos demonstrating the onset of uniform YFP expression in the E14.5 skin epithelium (scale …

Figure 2—figure supplement 1
Breeding strategy to generate the Mettl3 cKO animals and the control (Ctrl) littermates.

By mating the Mettl3+/fl, K14-Cre+/- and Mettl3fl/fl, Rosa26-YFPfl/fl breeders, we got offspring with 4 kinds of genotypes being born at Mendel’s ratio, among which Mettl3+/fl, Rosa26-YFP+/fl, …

Figure 2—figure supplement 2
Additional information on the Mettl3 cKO phenotypes.

(A) Representative pictures of P6 control and cKO littermates (scale bars: 1 cm). (B) Quantification of body weights of control and cKO littermates (error bars: standard deviation, for each …

Figure 2—figure supplement 2—source data 1

Quantification of neonates' body weights in (B).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig2-figsupp2-data1-v2.xlsx
Figure 2—figure supplement 2—source data 2

Quantification of TEWL in (C).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig2-figsupp2-data2-v2.xlsx
Figure 3 with 1 supplement
Loss of m6A results in diminished WNT signaling and signs of perturbed HF fate.

(A) Left panel: representative images from E17.5 sagittal sections immunolabeled for LEF1 and PCAD (scale bars: 50 µm). White solid lines denote skin surface and dashed lines denote dermal-epidermal …

Figure 3—source data 1

Quantification of LEF1 immunofluorescence signals at E17.5 in (A).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig3-data1-v2.xlsx
Figure 3—source data 2

Quantification of LEF1 immunofluorescence signals at P0 in (B).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig3-data2-v2.xlsx
Figure 3—figure supplement 1
Examination of METTL3 and YFP expression in the grafted skin.

Images of back skin engrafted to Nude (Nu/Nu) mice for 15 days immunolabeled for PCAD, METTL3 and YFP demonstrating in the grafted tissue METTL3 is still largely depleted in the cKO epithelium …

Figure 4 with 1 supplement
Perturbations in WNT-driven dermal papilla engulfment and in actin-mediated cellular polarity within Mettl3 cKO HFs.

(A) Ultrastructure of HF in control and Mettl3 cKO mice in P0 back skin. Matrix (Mx) cells engulf the dermal papilla (DP, colored in pink) in the control HF but often fail to do so in the cKO. …

Figure 4—figure supplement 1
Analysis of DNA fragmentation, apoptosis and cell division angles in HF morphogenesis.

(A) Quantification of TUNEL+ and cleaved Caspase-3+ cells in HFs at different developmental stages [placodes (Plcd), germs and pegs] at P0. Quantifications are from images of P0 sagittal sections …

Figure 4—figure supplement 1—source data 1

Quantification of cell death events in HFs in (A).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig4-figsupp1-data1-v2.xlsx
Figure 4—figure supplement 1—source data 2

Quantification of cell division angles in (B).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig4-figsupp1-data2-v2.xlsx
Figure 5 with 1 supplement
Single-cell transcriptomics of Mettl3 cKO compared to control skin epithelial lineages.

(A) YFP+ progenitors were FACS-enriched from E17 control and Mettl3 cKO whole back skins and subject to scRNA-seq as described in the Materials and methods. Shown are the data from unbiased …

Figure 5—figure supplement 1
Cell isolation for scRNA-seq analysis and cell identity verification.

(A) Images of E17.5 back skin sagittal sections before (whole skin, Wh) and after dispase treatment immunolabeled for PCAD demonstrating Mettl3 cKO affects the separation of developing HFs between …

Figure 6 with 2 supplements
Investigation of RNAs whose levels diminish upon METTL3 loss.

(A) scRNA-seq data from Figure 5A were binned according to four major classifications: Epi basal, Epi suprabasal, HF WNThi and HF WNTlo. Scatter plots of mRNAs in these cells were then analyzed …

Figure 6—figure supplement 1
Correlation between the levels of m6A modification and changes in steady-state RNA levels upon Mettl3 ablation.

Correlation analysis of the Z score (cKO/Ctrl) from scRNA-seq to different parameters of assessing m6A modification levels. The different parameters tested include m6A site number (site #), m6A site …

Figure 6—figure supplement 2
Additional analysis of epidermal perturbations upon Mettl3 cKO.

(A) Confocal images of E16.5 whole-mount back skin immunolabeled for PCAD, ECAD and YFP (scale bars: 20 µm). PCAD and ECAD expression was quantified in the basal progenitors of skin epithelium …

Figure 6—figure supplement 2—source data 1

Quantification of PCAD, ECAD immunofluorescence signals in (A).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig6-figsupp2-data1-v2.xlsx
Figure 6—figure supplement 2—source data 2

Quantification of EdU+ cells and the suprabasal/basal cell number ratio in (B).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig6-figsupp2-data2-v2.xlsx
Figure 6—figure supplement 2—source data 3

Quantification of cell sizes by cytospin in (C).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig6-figsupp2-data3-v2.xlsx
Figure 6—figure supplement 2—source data 4

Quantification of cell death events in epidermis in (F).

https://cdn.elifesciences.org/articles/56980/elife-56980-fig6-figsupp2-data4-v2.xlsx
Figure 7 with 1 supplement
Investigation of RNAs upregulated upon METTL3 loss.

(A) Scatter plots of mRNAs in the indicated groups of cells (as in Figure 5A) based on expression changes (cKO/Ctrl) assessed by scRNA-seq Z score and correlated with the coding sequence m6A density …

Figure 7—figure supplement 1
Additional analysis of features affected by the upregulated genes upon Mettl3 cKO.

(A) ECDF plots of the Z score (cKO/Ctrl) from scRNA-seq demonstrate transcripts with higher levels of m6A modification (assessed by the coding sequence SN-uTPM per nt value from miCLIP) in wild-type …

Tables

Appendix 1—key resources table
Reagent type
(species) or resource
DesignationSource or referenceIdentifiersAdditional information
Genetic reagent (M. musculus)C57BL/6JJackson labStock #: 000664
Genetic reagent (M. musculus)Mettl3floxPMID:31412241
J. Brüning (Max Planck Institute for Metabolism Research and Policlinic for Endocrinology, Diabetes and Preventive Medicine)
Genetic reagent (M. musculus)Krt14-CrePMID:10411913
E. Fuchs (Rockefeller University)
MGI:1926500
Genetic reagent (M. musculus)Rosa26-YFPfloxJackson labStock #: 006148
Genetic reagent (M. musculus)Gli-LacZPMID:12361967
A. Joyner (MSKCC)
MGI:2449767
Genetic reagent (M. musculus)Nude (Nu/Nu)Charles River LaboratoriesStrain code: 088
AntibodyRat anti-BrdUAbcamCat. #: ab6326
RRID:AB_305426
IMF (1:200)
AntibodyRat anti-CD104BD PharmingenCat. #: 553745
RRID: AB_395027
IMF (1:500)
AntibodyArmenian hamster anti-CD29BioLegendCat. #: 102201
RRID:AB_312878
IMF (1:500)
AntibodyRat anti-CD49fBioLegendCat. #: 313602
RRID:AB_345296
IMF (1:1000)
AntibodyRabbit anti-Cleaved Caspase-3R&D SystemsCat. #: AF835
RRID:AB_2243952
IMF (1:200)
AntibodyRabbit anti-ECADCell SignalingCat. #: 3195
RRID:AB_2291471
IMF (1:500)
AntibodyRabbit anti-FLGE. Fuchs (Rockefeller University)IMF (1:2000)
AntibodyRabbit anti-HES1E. Fuchs (Rockefeller University)IMF (1:200)
AntibodyRabbit anti-iNVBioLegendCat. #: 924401
RRID:AB_2565452
IMF (1:2000)
AntibodyGuinea pig anti-K5E. Fuchs (Rockefeller University)IMF (1:500)
AntibodyRabbit anti-K10CovanceCat. #: PRB-159P-100
RRID:AB_291580
IMF (1:1000)
Flow (1:500)
AntibodyGuinea pig anti-LEF1E. Fuchs (Rockefeller University)IMF (1:5000)
AntibodyRabbit anti-LHX2E. Fuchs (Rockefeller University)IMF (1:5000)
AntibodyRabbit anti-LORE. Fuchs (Rockefeller University)IMF (1:4000)
AntibodyRabbit anti-METTL3AbcamCat. #: ab195352
RRID:AB_2721254
IMF (1:100-1:500)
AntibodyRabbit anti-MYCAbcamCat. #: ab32072
RRID:AB_731658
IMF (1:100)
AntibodyGoat anti-PCADR&D SystemsCat. #: AF761
RRID:AB_355581
IMF (1:300-1:600)
AntibodyRabbit anti-SOX9MilliporeCat. #: AB5535
RRID:AB_2239761
IMF (1:1000)
AntibodyRabbit anti-SurvivinCell SignallingCat. #: 2808
RRID:AB_2063948
IMF (1:500)
AntibodyChicken anti-GFP/YFPAbcamCat. #: ab13970
RRID:AB_300798
IMF (1:1000-1:1200)
Antibodyanti-CD29 PECy7Thermo Fisher ScientificCat. #: 25-0291-82
RRID: AB_1234962
FACS (1:1000)
Antibodyanti-CD31 APCThermo Fisher ScientificCat. #: 17-0311-82
RRID:AB_657735
FACS (1:1000)
Antibodyanti CD45-APCThermo Fisher ScientificCat. #: 17-0451-83
RRID:AB_469393
FACS (1:1000)
Antibodyanti-CD49f PEThermo Fisher ScientificCat. #: 12-0495-81
RRID:AB_891478
FACS (1:1000)
Antibodyanti-CD49f PECy7Thermo Fisher ScientificCat. #: 25-0495-82
RRID:AB_10804881
FACS (1:1000)
Antibodyanti CD117-APCThermo Fisher ScientificCat. #: 17-1172-81
RRID:AB_469432
FACS (1:1000)
Antibodyanti CD140a-APCThermo Fisher ScientificCat. #: 17-1401-81
RRID:AB_529482
FACS (1:500)
AntibodyMouse anti-rabbit IgG PE-Cy7Santa CruzCat. #: sc-516721
Flow (1:300)
Chemical compound, drugAlexa Fluor 647 PhalloidinThermo Fisher ScientificCat. #: A22287
RRID:AB_2620155
IMF (1:50)
Commercial assay or kitIn situ cell death detection kit, TMR redSigma-AldrichCat. #: 12156792910
Commercial assay or kitClick-iT EdU cell proliferation kit for imaging, Alexa Fluor 647 dyeThermo Fisher ScientificCat. #: C10340
Commercial assay or kitLIVE/DEADfixable Aqua dead cell stain kit, for 405 nm excitationThermo Fisher ScientificCat. #: L34957
Commercial assay or kitFixation/ permeabilization solution kitBD BiosciencesCat. #: 554714
Commercial assay or kitDynabeads mRNA purification kitThermo Fisher ScientificCat. #: 61006
Commercial assay or kitDirect-zol RNA miniprep kitZymo ResearchCat. #: R2051
Commercial assay or kitRQ1 RNase-free DNasePromegaCat. #: M6101
Commercial assay or kitHigh-capacity cDNA reverse transcription kitThermo Fisher ScientificCat. #: 4368814
Commercial assay or kitPower SYBR Green PCR Master MixThermo Fisher ScientificCat. #: 4367660
Commercial assay or kitChromium single cell 3' reagent kit10x GenomicsCat. #: PN-120267
Chemical compound, drugTRI Reagent
LS
Sigma-AldrichCat. #: T3934
Software, algorithmZenZeisshttps://www.zeiss.com/microscopy/int/products/microscope-software/zen.html 
Software, algorithmFiji ImageJImageJhttps://imagej.net/Fiji
Software, algorithmAndor IQ3Oxford Instrumentshttps://andor.oxinst.com/products/iq-live-cell-imaging-software/
Software, algorithmGraphPad Prism 8.2GraphPadhttps://www.graphpad.com/
Software, algorithmBD FACSDivaBD Bioscienceshttps://www.bdbiosciences.com/en-us/instruments/research-instruments/research-software/flow-cytometry-acquisition/facsdiva-software
Software, algorithmFlowJoFlowJo, LLChttps://www.flowjo.com/solutions/flowjoVersion 10
Software, algorithmRCRANhttps://cran.r-project.orgR Version 3.6.3
Bioconductor Version 3.10
Software, algorithmFlexbarPMID:24832523https://github.com/seqan/flexbarVersion 2.5
Software, algorithmpyCRACS. Granneman (SynthSys)http://sandergranneman.bio.ed.ac.uk/pycrac-softwareVersion 1.1.3
Software, algorithmNovoalignNovocrafthttp://www.novocraft.com/products/novoalign/Version 3.04.06
Software, algorithmCIMSC. Zhang (Columbia University)https://zhanglab.c2b2.columbia.edu/index.php/CTK_Documentation
Software, algorithmBedtoolsPMID:20110278
A. Quinlan (University of Utah)
https://github.com/arq5x/bedtools2.gitVersion 2.25.0
Software, algorithmSamtoolsPMID:19505943
H. Li (Harvard University)
http://samtools.sourceforge.netVersion 1.2
Software, algorithmCell Ranger10x Genomicshttps://support.10xgenomics.com/single-cell-gene-expression/software/overview/welcomeVersion 2.1.1
Software, algorithmSeuratPMID:29608179
R. Satija (New York University)
https://satijalab.org/seurat/
Version 2.3.4
Software, algorithmMonoclePMID:28114287
C. Trapnell (University of Washington)
http://cole-trapnell-lab.github.io/monocle-release/Version 2.10.1
Software, algorithmMASTPMID:26653891
A. McDavid (University of Rochester Medical Center)
https://www.bioconductor.org/packages/release/bioc/html/MAST.htmlVersion 1.8.2

Additional files

Supplementary file 1

Summary of all identified m6A sites through miCLIP.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp1-v2.xlsx
Supplementary file 2

Quantification of m6A levels based on the sum of normalized-to-input uTPM value of m6A along coding sequence (CDS SN-uTPM) and GSEA.

First sheet: Rank of mRNAs based on coding sequence SN-uTPM. Second sheet: GSEA of mRNAs weighted on coding sequence SN-uTPM. The gene sets with p values <0.25 are shown. Third sheet: GSEA of mRNAs with top 20% coding sequence SN-uTPM and top 20% translation efficiency. The gene sets with p values <0.10 are shown.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp2-v2.xlsx
Supplementary file 3

Differential gene expression analysis through scRNA-seq.

The extent of differential gene expression assessed by Z score (reflecting the extent of differential expression) and false discovery rate (FDR) was calculated between groups of Ctrl and cKO cells with the same identity, as indicated by sheet names in the file.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp3-v2.xlsx
Supplementary file 4

Different parameters used to assess m6A modification levels.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp4-v2.xlsx
Supplementary file 5

GSEA of transcripts with Z score (cKO/Ctrl)>1.96, FDR <0.05 in scRNA-seq and m6A coding sequence SN-uTPM per nt among the top 20%.

The gene sets with p values <0.05 are shown.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp5-v2.xlsx
Supplementary file 6

Sequences of genotyping and qPCR primers used in this study.

https://cdn.elifesciences.org/articles/56980/elife-56980-supp6-v2.xlsx
Transparent reporting form
https://cdn.elifesciences.org/articles/56980/elife-56980-transrepform-v2.pdf

Download links